Stock screenerAll disclosures →
EDGAR →
ARTV
Conviction 45HealthcareScan · Mon, Jul 20, 2026ARTV$9.20-5.74%
ResistanceSupportVol 14Insider buyInsider sell16
5
Vol MA14 468.98K
Apr 20May 6May 26Jun 11Jul 1Jul 20
Price9.20
Change-5.74%
Gap+0.92%
Rel volume0.85×
Avg volume499.35K
Avg $ vol4.72M
SMA 209.46
SMA 508.97
SMA 2006.15
Price vs 50+2.51%
Price vs 200+49.48%
MA stackbullish
50/200 cross—
Supertrendup · 7.20
RSI (14)50
MACD hist-0.04
MACD crossbear · 5d
Stoch %K / %D30 / 39
ADX (14)17
+DI / −DI15 / 11
RSI divergenceBearish
MACD divergenceBearish
ATR %+9.61%
ADR %8.77%
52w high13.39
52w low2.28
From 52w high-31.29%
Above 52w low+303.51%
New 52w highNo
SqueezeOn · 8d
Bollinger width12.24%
%B0.28
Donchian pos40.66%
Donchian high10.28
Donchian low8.46
AVWAP (52w high)9.54
vs AVWAP high-3.53%
AVWAP (52w low)6.17
vs AVWAP low+48.99%
OBV trendFlat
Chaikin MF (20)-0.08
Today vs 20d0.85×
Avg vol (14d)468.98K
Avg vol (20d)499.35K
Avg $ vol (20d)4.72M
Market cap227.39M
RS 3m (vs SPY)-25.34%
RS 6m (vs SPY)+96.52%
RS line new highNo
Trend template6/8
Technical rank75.2
1 week+3.02%
1 month-7.44%
3 months-26.69%
6 months+106.28%
1 year+255.21%
YTD+117.49%
P/E-2.71
P/B2.59
P/S6.91
P/FCF-2.87
EPS-3.43
Div yield—
ROE-95.47%
ROA-79.15%
Debt/Eq—
Current8.16
EV/EBITDA-2.37
Gross margin—
Net margin-254.73%
Rev growth—
EPS growth-28.29%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value206.44M
Revenue26.66M
Net income-23.52M
Gross profit—
Free cash flow-79.34M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out24.72M
Employees106
ListedFri, Jul 19, 2024
Free float5.69M
Float %23.2%
Short interest1.34M
Days to cover1.8d
Short volume55.9%
Squeeze score60 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeC
Conviction45 / 100
Pattern quality—
Tech rank75.2 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance10.39
Support6.65
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ARTV
No recent disclosed trades by Congress in ARTV. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ARTV · 9 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. Director · Common Stock · 2026-06-26 | Buy | 1.88K | $17K | 2026-06-26 | 2026-06-29 |
RA CAPITAL MANAGEMENT, L.P. Director · Common Stock · 2026-06-25 | Buy | 31K | $275K | 2026-06-25 | 2026-06-29 |
RA CAPITAL MANAGEMENT, L.P. Director · Common Stock · 2026-06-16 | Buy | 124.89K | $1.1M | 2026-06-16 | 2026-06-16 |
RA CAPITAL MANAGEMENT, L.P. Director · Common Stock · 2026-06-15 | Buy | 15.41K | $139K | 2026-06-15 | 2026-06-16 |
RA CAPITAL MANAGEMENT, L.P. Director · Common Stock · 2026-06-12 | Buy | 391.02K | $3.4M | 2026-06-12 | 2026-06-16 |
GC Corp. 10% owner · Common Stock · 2026-05-11 | Buy | 347.22K | $4.0M | 2026-05-11 | 2026-05-28 |
GC Cell Corp 10% owner · Common Stock · 2026-05-11 | Buy | 1.09M | $12M | 2026-05-11 | 2026-05-28 |
GC Cell Corp 10% owner · Common Stock · 2026-05-11 | Buy | 347.22K | $4.0M | 2026-05-11 | 2026-05-28 |
GC Corp. 10% owner · Common Stock · 2026-05-11 | Buy | 1.09M | $12M | 2026-05-11 | 2026-05-28 |
Banerjee Subhashis Chief Medical Officer · Common Stock · 2026-05-19 | Sell | 7.04K | $63K | 2026-05-19 | 2026-05-19 |
SEC filings
EDGAR filings in ARTV · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.